Leading Companies

NOUSCOM AG

Nouscom is a biotech company developing next generation immunotherapies in the field of oncology. Nouscom’s proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

NOUSCOM AG

Bäumleingasse 18
4051 Basel
Switzerland


Secteurs
Bio Technology (Biotech)
Life Science
Country of Origin
Italie
En savoir plus sur le sujet
Partager

Partenaire Premium

Partenaires stratégiques

Partenaire institutionnel

Programme officiel